Core Nursing Explanation
Key Concept Analysis: This question tests the priority nursing intervention for a pregnant patient with
Gestational Diabetes Mellitus (GDM) who presents with poorly controlled blood glucose. The core pathophysiological principle is that maternal hyperglycemia leads to fetal hyperglycemia, which stimulates the fetal pancreas to produce excess insulin. This fetal hyperinsulinemia acts as a growth hormone, leading to
Macrosomia (large-for-gestational-age baby). More critically, it increases the risk of
Fetal distress,
Intrauterine fetal demise (IUFD), and neonatal complications like hypoglycemia after birth. Therefore, when maternal glucose control is suboptimal, the immediate nursing priority shifts from managing the mother's glucose to
Key Point! assessing and ensuring fetal well-being.
Answer Rationale: Option ② is correct because it directly addresses the most significant and immediate risk: potential fetal compromise. A fasting glucose of
140 mg/dL (target is typically
< 95 mg/dL) and a postprandial of
180 mg/dL (target is typically
< 120-140 mg/dL) indicate poor control.
Assessing fetal movement is a quick, non-invasive initial assessment, and scheduling a
Non-Stress Test (NST) is a standard, immediate intervention to evaluate fetal heart rate reactivity and rule out distress. This aligns with the nursing process principle of prioritizing interventions based on the greatest threat to the patient (in this case, the fetus).
Distractor Analysis:
- Option ① (Administer insulin): While administering prescribed insulin is a correct and necessary action for glucose management, it is not the priority in this specific scenario. The question presents a situation where hyperglycemia is already present and has been sustained long enough to pose a fetal risk. The priority is to first assess the status of the fetus who may already be in distress due to the existing hyperglycemia. Insulin administration addresses the cause but does not immediately assess the effect on the fetus.
- Option ③ (Strict bed rest): Bed rest is not a standard or evidence-based intervention for GDM management. It is more commonly associated with preterm labor, preeclampsia, or placenta previa. There is no indication in the scenario (like contractions or bleeding) to suggest preterm labor is the immediate concern. This intervention is unrelated to the primary problem of hyperglycemia and fetal surveillance.
- Option ④ (Increase dietary carbohydrates): This intervention is contraindicated and dangerous. For a patient with hyperglycemia, the dietary management focuses on controlled, consistent carbohydrate intake, not an increase. Increasing carbohydrates would worsen the hyperglycemia, exacerbating the risk to the fetus.
Related Concepts: The management of GDM follows a stepwise approach: medical nutrition therapy first, then pharmacotherapy (insulin or oral agents like glyburide) if needed. However,
Watch out for confusion! When glucose control is poor, fetal surveillance becomes paramount. Other tests for fetal well-being include the
Biophysical Profile (BPP) and
Doppler velocimetry. Neonatal risks include hypoglycemia, hyperbilirubinemia, and respiratory distress syndrome.
Concept Summary
| Concept | Key Points |
| Gestational Diabetes (GDM) | Glucose intolerance first recognized in pregnancy. Risks: maternal preeclampsia, cesarean birth; fetal macrosomia, birth injury, neonatal hypoglycemia. |
| Fetal Surveillance in GDM | Priority when glucose is poorly controlled. Methods: Kick counts, Non-Stress Test (NST), Biophysical Profile (BPP). Goal: Detect fetal distress early. |
| Glucose Targets in Pregnancy | Fasting: < 95 mg/dL. 1-hr postprandial: < 140 mg/dL. 2-hr postprandial: < 120 mg/dL. |
| Pathophysiology of Fetal Risk | Maternal glucose crosses placenta → Fetal hyperglycemia → Fetal pancreatic hyperplasia & hyperinsulinemia → Macrosomia, increased metabolic demands, risk of IUFD. |
Side-by-Side Comparison!
| Intervention | When It's a Priority | Rationale |
| Fetal Surveillance (NST, BPP) | Poorly controlled maternal diabetes (any type), decreased fetal movement, post-term pregnancy, hypertension. | Hyperglycemia/hypoxia can cause fetal distress or demise. Assessment is immediate and life-saving. |
| Administering Insulin | As part of the ongoing management plan when diet/exercise fails to control glucose. | Addresses the root cause (hyperglycemia) but has a delayed effect on fetal status. Must be paired with surveillance. |
| Monitoring for Preterm Labor | History of preterm birth, multiple gestation, cervical insufficiency, symptoms present (cramping, contractions). | Not the primary risk factor for isolated GDM unless other complications coexist. |
Anatomy, Physiology & Pharmacology Points
- Placental Function: Glucose crosses the placenta via facilitated diffusion. Insulin does NOT cross the placenta, which is why maternal insulin is safe for the fetus.
- Fetal Pancreas: By the second trimester, the fetal pancreas can produce insulin in response to maternal glucose levels.
- Insulin in Pregnancy: The drug of choice for GDM when pharmacotherapy is needed. Human insulin or insulin analogs are used. Oral agents like glyburide may be used in some cases but cross the placenta.
Memory Tips
- Priority Acronym: "Fetus First in Diabetes" – When mom's sugars are high, check the baby or it may die.
- Glucose Numbers: Remember "